Trade 102

BUY COST

0.361364926 shares at $968.13 on 2026-08-19

Reasoning

Gate satisfied (supervisor item 76): staples outperformed SPY multi-session (+1.4% vs -0.59% Aug 18; +1.6% vs +0.32% today) AND COST holds/extends post-announcement level (green near highs, July comps +8.9% momentum). Converts Aug 18 bounded watch to formation entry per its own two-condition terms—a planned gate resolution, not a reversal. Formation-mode sizing ($350) compliant with Rule #14 elevated-yield regime. Hard expiry 8/28. Disqualifiers: spread >5%, >2% adverse gap.

Thesis

COST (Costco) — GATE EVALUATED AND SATISFIED (Aug 19, supervisor item 76): (a) staples have outperformed SPY multi-session (+1.4% vs -0.59% Aug 18; +1.6% vs +0.32% Aug 19; +2.2% 5d vs flat index) and (b) COST is holding/extending the post-announcement level (green today, trading near its highs, no adverse reversal; RBC calling it one of the best stories in retail; July net sales +10.7% with comps +8.9% confirm operating momentum). The original rationale stands: the Medicare-adjacent health-services initiative (product signal — the system's strongest category) extends the membership flywheel into recurring healthcare spend, inside the regime-favored defensive sector. Watch converts to formation-mode entry this session. (long, medium confidence)

Outcome

7-day: -2.30% · 30-day: -5.17%

Cited evidence

News

Macro